Perceived Quality of Care is Associated with Disease Activity, Quality of Life, Work Productivity, and Gender, but not Disease Phenotype: A Prospective Study in a High-volume IBD Centre.


Journal

Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676

Informations de publication

Date de publication:
19 Sep 2019
Historique:
pubmed: 23 2 2019
medline: 13 2 2020
entrez: 23 2 2019
Statut: ppublish

Résumé

Measuring quality of care [QoC] in inflammatory bowel diseases [IBD] has become increasingly important, yet complex assessment of QoC from the patients' perspective is rare. We evaluated perceived QoC using the Quality of Care Through the Patient's Eyes-IBD [QUOTE-IBD] questionnaire, and investigated associations between QoC, disease phenotype, work productivity, and health-related quality of life [HRQoL] in a high-volume IBD centre. Consecutive patients attending McGill University Health Centre [MUHC]-IBD Centre completed the QUOTE-IBD, Short Inflammatory Bowel Disease Questionnaire [SIBDQ], IBD-Control, and Work Productivity and Activity Impairment [WPAI] questionnaires. The QUOTE-IBD comprises 23 questions, each rated by a quality impact [QI] score. QI scores were calculated for the evaluation of IBD specialists, general practitioners [GPs], and hospital care. In all, 525 patients completed the questionnaire. Total QI scores for IBD specialists, GPs, and hospital care were 8.57, 8.70, and 8.33, respectively. The lowest QI scores were related to 'accessibility' for both IBD specialists and GPs. Female gender, current disease activity, poor HRQoL [SIBDQ score ≤50], and poor disease control [IBD-Control score <13] were associated with lower mean QI scores [p <0.001 for all]. Disease phenotype was not associated with QI scores in either Crohn's disease [CD] or ulcerative colitis [UC] [p = 0.69, p = 0.791, respectively]. An inverse correlation was found between total QI scores and work productivity loss [IBD specialist: p <0.001; GP: p = 0.004]. Overall patient satisfaction with QoC was good; however, improving patient accessibility to care is warranted. Disease phenotype was not associated with patient satisfaction, whereas female gender, current disease activity, HRQoL, and work productivity loss were associated with patients' quality assessment, underlining that perceived QoC could be partly subjective regarding disease control and quality of life.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Measuring quality of care [QoC] in inflammatory bowel diseases [IBD] has become increasingly important, yet complex assessment of QoC from the patients' perspective is rare. We evaluated perceived QoC using the Quality of Care Through the Patient's Eyes-IBD [QUOTE-IBD] questionnaire, and investigated associations between QoC, disease phenotype, work productivity, and health-related quality of life [HRQoL] in a high-volume IBD centre.
METHODS METHODS
Consecutive patients attending McGill University Health Centre [MUHC]-IBD Centre completed the QUOTE-IBD, Short Inflammatory Bowel Disease Questionnaire [SIBDQ], IBD-Control, and Work Productivity and Activity Impairment [WPAI] questionnaires. The QUOTE-IBD comprises 23 questions, each rated by a quality impact [QI] score. QI scores were calculated for the evaluation of IBD specialists, general practitioners [GPs], and hospital care.
RESULTS RESULTS
In all, 525 patients completed the questionnaire. Total QI scores for IBD specialists, GPs, and hospital care were 8.57, 8.70, and 8.33, respectively. The lowest QI scores were related to 'accessibility' for both IBD specialists and GPs. Female gender, current disease activity, poor HRQoL [SIBDQ score ≤50], and poor disease control [IBD-Control score <13] were associated with lower mean QI scores [p <0.001 for all]. Disease phenotype was not associated with QI scores in either Crohn's disease [CD] or ulcerative colitis [UC] [p = 0.69, p = 0.791, respectively]. An inverse correlation was found between total QI scores and work productivity loss [IBD specialist: p <0.001; GP: p = 0.004].
CONCLUSIONS CONCLUSIONS
Overall patient satisfaction with QoC was good; however, improving patient accessibility to care is warranted. Disease phenotype was not associated with patient satisfaction, whereas female gender, current disease activity, HRQoL, and work productivity loss were associated with patients' quality assessment, underlining that perceived QoC could be partly subjective regarding disease control and quality of life.

Identifiants

pubmed: 30793162
pii: 5355776
doi: 10.1093/ecco-jcc/jjz035
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1138-1147

Informations de copyright

Copyright © 2019 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Lorant Gonczi (L)

First Department of Medicine, Semmelweis University, Budapest, Hungary.

Zsuzsanna Kurti (Z)

First Department of Medicine, Semmelweis University, Budapest, Hungary.

Christine Verdon (C)

Inflammatory Bowel Disease Centre, McGill University Health Centre [MUHC], Montreal, QC, Canada.

Jason Reinglas (J)

Inflammatory Bowel Disease Centre, McGill University Health Centre [MUHC], Montreal, QC, Canada.

Rita Kohen (R)

Inflammatory Bowel Disease Centre, McGill University Health Centre [MUHC], Montreal, QC, Canada.

Isabelle Morin (I)

Inflammatory Bowel Disease Centre, McGill University Health Centre [MUHC], Montreal, QC, Canada.

Kelly Chavez (K)

Inflammatory Bowel Disease Centre, McGill University Health Centre [MUHC], Montreal, QC, Canada.

Talat Bessissow (T)

Inflammatory Bowel Disease Centre, McGill University Health Centre [MUHC], Montreal, QC, Canada.

Waqqas Afif (W)

Inflammatory Bowel Disease Centre, McGill University Health Centre [MUHC], Montreal, QC, Canada.

Gary Wild (G)

Inflammatory Bowel Disease Centre, McGill University Health Centre [MUHC], Montreal, QC, Canada.

Ernest Seidman (E)

Inflammatory Bowel Disease Centre, McGill University Health Centre [MUHC], Montreal, QC, Canada.

Alain Bitton (A)

Inflammatory Bowel Disease Centre, McGill University Health Centre [MUHC], Montreal, QC, Canada.

Peter L Lakatos (PL)

First Department of Medicine, Semmelweis University, Budapest, Hungary.
Inflammatory Bowel Disease Centre, McGill University Health Centre [MUHC], Montreal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH